Rodman & Renshaw analyst Elemer Piros initiated coverage of Forte Biosciences with a Buy rating and $4 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on FBRX: Forte Biosciences initiated with a Buy at Brookline Forte Biosciences reports Q1 EPS (16c), two estimates (16c) Forte Biosciences Inc. (FBRX) Q1 Earnings Cheat Sheet Disclaimer & DisclosureReport an Issue
